These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9742289)

  • 61. Pharmacokinetic interaction between imipramine and carbamazepine in patients with major depression.
    Szymura-Oleksiak J; Wyska E; Wasieczko A
    Psychopharmacology (Berl); 2001 Feb; 154(1):38-42. PubMed ID: 11292004
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A comprehensive investigation of plasma and brain regional pharmacokinetics of imipramine and its metabolites during and after chronic administration in the rat.
    Besret L; Debruyne D; Rioux P; Bonvalot T; Moulin M; Zarifian E; Baron JC
    J Pharm Sci; 1996 Mar; 85(3):291-5. PubMed ID: 8699331
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Synergistic effect of imipramine and amantadine in the forced swimming test in rats. Behavioral and pharmacokinetic studies.
    Rogóz Z; Skuza G; Kuśmider M; Wójcikowski J; Kot M; Daniel WA
    Pol J Pharmacol; 2004; 56(2):179-85. PubMed ID: 15156068
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Thyroid function and thyroid tumors in toxaphene-treated rats.
    Waritz RS; Steinberg M; Kinoshita FK; Kelly CM; Richter WR
    Regul Toxicol Pharmacol; 1996 Oct; 24(2 Pt 1):184-92. PubMed ID: 8933632
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Blood and brain concentrations of imipramine, clomipramine and their monomethylated metabolites after oral and intramuscular administration in rats.
    Nagy A
    J Pharm Pharmacol; 1977 Feb; 29(2):104-7. PubMed ID: 15053
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Urinary desipramine hydroxylation index and steady-state plasma concentrations of imipramine and desipramine.
    Spina E; Arena A; Pisani F
    Ther Drug Monit; 1987 Jun; 9(2):129-33. PubMed ID: 3617150
    [TBL] [Abstract][Full Text] [Related]  

  • 67. First-pass metabolism of imipramine and desipramine: impact of the sparteine oxidation phenotype.
    Brøsen K; Gram LF
    Clin Pharmacol Ther; 1988 Apr; 43(4):400-6. PubMed ID: 3356084
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction.
    Bergstrom RF; Peyton AL; Lemberger L
    Clin Pharmacol Ther; 1992 Mar; 51(3):239-48. PubMed ID: 1544284
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of phenobarbitone on the distribution and elimination of imipramine in rats.
    Lin TH; Sawada Y; Sugiyama Y; Iga T; Hanano M
    J Pharm Pharmacol; 1985 Oct; 37(10):735-8. PubMed ID: 2867146
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Increased hippocampal nitric oxide synthase activity and stress responsiveness after imipramine discontinuation: role of 5HT 2A/C-receptors.
    Harvey BH; Retief R; Korff A; Wegener G
    Metab Brain Dis; 2006 Sep; 21(2-3):211-20. PubMed ID: 16865538
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response.
    Perry PJ; Zeilmann C; Arndt S
    J Clin Psychopharmacol; 1994 Aug; 14(4):230-40. PubMed ID: 7962678
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The clinical application of tricyclic antidepressant pharmacokinetics and plasma levels.
    Amsterdam J; Brunswick D; Mendels J
    Am J Psychiatry; 1980 Jun; 137(6):653-62. PubMed ID: 6990798
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Enhancement of antidepressant-like activity by joint administration of imipramine and magnesium in the forced swim test: Behavioral and pharmacokinetic studies in mice.
    Poleszak E; Wlaź P; Szewczyk B; Kedzierska E; Wyska E; Librowski T; Szymura-Oleksiak J; Fidecka S; Pilc A; Nowak G
    Pharmacol Biochem Behav; 2005 Jul; 81(3):524-9. PubMed ID: 15936065
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prediction of steady-state imipramine and desmethylimipramine plasma concentrations from single-dose data.
    Brunswick DJ; Amsterdam JD; Mendels J; Stern SL
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):605-10. PubMed ID: 436362
    [TBL] [Abstract][Full Text] [Related]  

  • 75. alpha 1-acid glycoprotein involvement in high affinity binding of tricyclic antidepressants to human plasma.
    Javaid JI; Hendricks K; Davis JM
    Biochem Pharmacol; 1983 Apr; 32(7):1149-53. PubMed ID: 6847707
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of combined administration of diazepam and imipramine hydrochloride in rats.
    Okiyama M; Ueno K; Ohkawara S; Ohmori S; Igarashi T; Kitagawa H
    J Pharm Sci; 1986 Nov; 75(11):1071-5. PubMed ID: 3820101
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A comparison of plasma and serum levels of two tricyclic antidepressants: imipramine and desipramine.
    Saady JJ; Bloom VL; Narasimhachari N; Goldberg SC; Friedel RO
    Psychopharmacology (Berl); 1981; 75(2):173-4. PubMed ID: 6798606
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of fluvoxamine on the pharmacokinetics of imipramine and desipramine in healthy subjects.
    Spina E; Pollicino AM; Avenoso A; Campo GM; Perucca E; Caputi AP
    Ther Drug Monit; 1993 Jun; 15(3):243-6. PubMed ID: 8333005
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The route of administration of imipramine as a factor affecting formation of its metabolite desipramine.
    Daniel W; Adamus A; Melzacka M; Szymura J
    J Pharm Pharmacol; 1982 Oct; 34(10):678-80. PubMed ID: 6128396
    [No Abstract]   [Full Text] [Related]  

  • 80. The effects of antidepressants on the thyroid axis in depression.
    Shelton RC; Winn S; Ekhatore N; Loosen PT
    Biol Psychiatry; 1993 Jan; 33(2):120-6. PubMed ID: 8439600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.